Cargando…
Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells
Pancreatic cancer is a highly aggressive malignancy with limited treatment options. Type-I interferons (e.g. IFN-α/-β) have several anti-tumour activities. Over the past few years, clinical studies evaluating the effect of adjuvant IFN-α therapy in pancreatic cancer yielded equivocal results. Althou...
Autores principales: | Booy, Stephanie, van Eijck, Casper H J, Dogan, Fadime, van Koetsveld, Peter M, Hofland, Leo J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955155/ https://www.ncbi.nlm.nih.gov/pubmed/24460759 http://dx.doi.org/10.1111/jcmm.12200 |
Ejemplares similares
-
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
por: Blaauboer, Amber, et al.
Publicado: (2020) -
The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
por: Blaauboer, Amber, et al.
Publicado: (2022) -
Type I interferon
por: Niewold, Timothy B.
Publicado: (2020) -
Type-I interferons in atherosclerosis
por: Chen, Hung-Jen, et al.
Publicado: (2019) -
Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
por: Veenstra, Marije J., et al.
Publicado: (2016)